References
- Aouali N, Eddabra L, Macadré J, Morjani H. 2005. Immunosuppressors and reversion of multidrug-resistance. Crit Rev Oncol Hematol 56:61–70.
- Azhari H. 2010. Basics of biomedical ultrasound for engineers. Hoboken, NJ: John Wiley & Sons Ltd. pp. 153–190.
- Bisognol G, Cowiel F, Boddy A, Thomas HD, Dick G, Pinkerton CR. 1998. High-dose cyclosporin with etoposide-toxicity and pharmacokinetic interaction in children with solid tumours. Br J Cancer 77:2304–2309.
- Dhawan A, Bajpayee M, Parmar D. 2009. Comet assay: A reliable tool for the assessment of DNA damage in different models. Cell Biol Toxicol 25:5–32.
- Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. 2012. Molecular mechanisms of cisplatin resistance. Oncogene 31:1869–1883.
- Gilbert DC, Chalmers AJ, El-Khamisy SF. 2012. Topoisomerase I inhibition in colorectal cancer: Biomarkers and therapeutic targets. Br J Cancer 106:18–24.
- He H, Yu T, Zhang Y. 2012. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers. Ultraschall Med 33:275–282.
- Iman RL. 1982. Some aspects of the rank transform in analysis of variance problems. Proc 7th Annu SAS Users Group Int Conf 676–680.
- Khan A, Manna K, Bose C, Sinha M, Das DK, Kesh SB, Chakrabarty A, Banerji A, Dey S. 2013. Gossypetin, a naturally occurring hexahydroxy flavone, ameliorates gamma radiation-mediated DNA damage. Int J Radiat Biol 89:965–975.
- Jin ZJ. 2004. About the evaluation of drug combination. Acta Pharmacol Sin 25:146–147.
- Końca K, Lankoff A, Banasik A, Lisowska H, Kuszewski T, Góźdź S, Koza Z, Wojcik A. 2003. A cross-platform public domain PC image-analysis program for the comet assay. Mutat Res 534:15–20.
- Liang L, Xie S, Jiang J, Jin H, Li S, Liu J. 2013. The combined effects of hematoporphyrin monomethyl ether-SDT and doxorubicin on the proliferation of QBC939 cell lines. Ultrasound Med Biol 39:146–160.
- Linghu L, Tan Y, Lou Y, Hu L, Yang H, Yu T. 2013. Nanosecond electric pulses induce DNA breaks in cisplatin-sensitive and -resistant human ovarian cancer cells. Biochem Biophys Res Commun 430:695–699.
- Miklavčič D, Šemrov D, Mekid H, Mir LM. 2000. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73–83.
- Milowska K, Gabryelak T. 2007. Reactive oxygen species and DNA damage after ultrasound exposure. Biomol Eng 24:263–267.
- Mo S, Coussios CC, Seymour L, Carlisle R. 2012. Ultrasound-enhanced drug delivery for cancer. Expert Opin Drug Deliv 9:1525–1538.
- Morjani H, Madoulet C. 2010. Immunosuppressors as multidrug resistance reversal agents. Methods Mol Biol 59:433–446.
- Mutch DG, Herzog TJ, Chen CA, Collins JL. 1992. The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin. Gynecol Oncol 47:28–33.
- Olive PL, Banáth JP. 2006. The comet assay: A method to measure DNA damage in individual cells. Nat Protoc 1:23–29.
- Sheskin DJ. 2000. Handbook of parametric and nonparametric statistics procedures. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC, Test 11.
- Stoddart MJ. 2011. WST-8 analysis of cell viability during osteogenesis of human mesenchymal stem cells. Methods Mol Biol 740:21–25.
- Szerencsi Á, Kubinyi G, Váliczkó É, Juhász P, Rudas G, Mester Á, Jánossy G, Bakos J, Thuróczy G. 2013. DNA integrity of human leukocytes after magnetic resonance imaging. Int J Radiat Biol 89:870–876.
- Yu T, Bai J, Hu K, Wang Z. 2004. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro. Ultrason Sonochem 11:89–94.
- Yu T, Li S, Zhao J, Mason TJ. 2006a. Ultrasound: A chemotherapy sensitizer. Technol Cancer Res Treat 6:51–60.
- Yu T, Fan X, Xiong S, Hu K, Wang Z. 2006b. Microbubbles assist goat liver ablation by high intensity focused ultrasound. Eur Radiol 16:1557–1563.
- Yu T, Zhang Y, He H, Zhou S, Liu Y, Huang P. 2011. Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin. Mol Pharm 8:1408–1415.
- Yu T, Fu X. 2014. Extracorporeal ultrasound-guided high intensity focused ultrasound: Implications from the present clinical trials. Sci World J 2014:537260.
- Zhou YZ, Chen HZ, Yang QY, Liu SQ, Hou HY. 1996. Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance. Natl Med J China 76:680–683.